Healtheast Medical Research Institute
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$40,758,524
Other Assets
49%
Receivables (Non-Related)
38%
Property, Plant, & Equipment (net)
11%
Inventories
1%
Cash & Equivalents
0%
Related-Party Receivables
0%
Prepaid Expenses
0%
Investments
0%
Liabilities in 2024 (Year End)
$257,817,830
Other Liabilities
98%
Payables & Accruals
2%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,205
-
-
Receivables (Non-Related)
$14,558,168
$15,608,509
+7%
Related-Party Receivables
$0
$0
-
Inventories
$404,176
$421,993
+4%
Prepaid Expenses
$0
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
$4,774,360
$4,664,624
-2%
Other Assets
$20,908,558
$20,063,398
-4%
Total Assets
$40,648,467
$40,758,524
+0%
Liabilities
2023
2024
Change
Payables & Accruals
$5,479,002
$6,298,880
+15%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
$0
$0
-
Other Liabilities
$223,792,102
$251,518,950
+12%
Total Liabilities
$229,271,104
$257,817,830
+12%
Net assets
2023
2024
Change
Restricted Net Assets
-
$165,596
-
Unrestricted Net Assets
-
-$217,224,902
-
Net assets
2023
2024
Change
Net assets
-$188,622,637
-$217,059,306
-15%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)